Reneo Pharmaceuticals News | Markets Insider

June 2024 · 6 minute read
Menu icon A vertical stack of three evenly spaced horizontal lines. Markets Insider logo The word "Markets Insider". Markets Stocks Indices Commodities Cryptocurrencies Currencies ETFs News Calendar icon An icon in the shape of a calendar. Economic Earnings Search icon A magnifying glass. It indicates, "Click to perform a search". Markets Insider logo The word "Markets Insider". Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. Business Insider logo The words "Business Insider"

TipRanks 81d

Mitchell Kapoor’s Hold Rating on Reneo Pharmaceuticals Amid OnKure Merger and Oncology Pipeline Potential

RTTNews 82d

Reneo Pharmaceuticals, OnKure To Merge

GlobeNewswire 82d

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Seeking Alpha 82d

Reneo Pharmaceuticals gains on deal to merge with OnKure

TipRanks 85d

Maintaining Hold on Reneo Pharmaceuticals Amidst Strategic Uncertainties and Pipeline Setbacks

InvestorPlace 88d

RPHM Stock Earnings: Reneo Pharmaceuticals Beats EPS for Q1 2024

GlobeNewswire 88d

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

Seeking Alpha 88d

Reneo Pharmaceuticals GAAP EPS of -$0.25

TipRanks 125d

Sell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price Target

Seeking Alpha 128d

Reneo Pharmaceuticals GAAP EPS of -$2.52

InvestorPlace 128d

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023

GlobeNewswire 128d

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

Benzinga 220d

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga 220d

Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

TipRanks 228d

Analysts Offer Insights on Healthcare Companies: Rain Therapeutics (RAIN), Reneo Pharmaceuticals (RPHM) and Bicycle Therapeutics (BCYC)

Benzinga 232d

5 Analysts Have This to Say About Reneo Pharmaceuticals

TipRanks 232d

Hold Rating on Reneo Pharmaceuticals Following Lead Drug Trial Failure and Strategic Uncertainty

TipRanks 232d

Hold Rating and Lowered Price Target for Reneo Pharmaceuticals Following STRIDE Study Setback and Operational Challenges

Benzinga 233d

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

GlobeNewswire 233d

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

TipRanks 261d

Positive Outlook for Reneo Pharmaceuticals: Promising Clinical Trials and Strong Financial Position Underpin Buy Recommendation

TipRanks 263d

Wall Street Analysts Are Bullish on Top Healthcare Picks

GlobeNewswire 264d

Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

GlobeNewswire 275d

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire 283d

Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings

TipRanks 296d

Analysts Offer Insights on Healthcare Companies: Reneo Pharmaceuticals (RPHM), Astria Therapeutics (ATXS) and Scholar Rock Holding (SRRK)

TipRanks 297d

Analysts Offer Insights on Healthcare Companies: Reneo Pharmaceuticals (RPHM), Pulmonx (LUNG) and Orchestra BioMed Holdings (OBIO)

TipRanks 298d

Wall Street Analysts Are Bullish on Top Healthcare Picks

TipRanks 298d

Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Reneo Pharmaceuticals (RPHM)

GlobeNewswire 299d

Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

GlobeNewswire 302d

Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit

TipRanks 330d

H.C. Wainwright Keeps Their Buy Rating on Reneo Pharmaceuticals (RPHM)

GlobeNewswire 340d

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences

Seeking Alpha 341d

HC Wainwright starts Reneo at buy, sees possible 2025 launch for lead drug

Benzinga 341d

Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023

TipRanks 358d

Reneo Pharmaceuticals (RPHM) Receives a Buy from Robert W. Baird

Seeking Alpha 359d

Reneo Pharmaceuticals GAAP EPS of -$0.65 misses by $0.13

TipRanks 373d

Bank of America Says These 2 Stocks Could Double Your Money — Here’s Why They Could Rally

Benzinga 397d

Benzinga's Top Ratings Upgrades, Downgrades For July 3, 2023

Seeking Alpha 397d

Tesla, Li Auto, Fidelity National Information Services among premarket gainers' pack

TipRanks 397d

Reneo Pharmaceuticals (RPHM) Receives a New Rating from Bank of America Securities

RTTNews 403d

Pre-market Movers: ASTC, RPHM, AEL, MEDS, OCFT…

Seeking Alpha 404d

Reneo Pharmaceuticals to join Russell 3000 index

TipRanks 440d

Insiders Pour $1 Million Each Into These 2 ‘Strong Buy’ Stocks⁠ — Here’s Why Wall Street Thinks They Could Double (or More)

TipRanks 440d

Insiders Pour $1 Million Each Into These 2 ‘Strong Buy’ Stocks⁠ — Here’s Why Wall Street Thinks They Could Double (or More)

TipRanks 445d

Reneo Pharmaceuticals (RPHM) Receives a Buy from SVB Securities

TipRanks 446d

Analysts Conflicted on These Healthcare Names: Pacira Pharmaceuticals (PCRX), Reneo Pharmaceuticals (RPHM) and Elanco Animal Health (ELAN)

TipRanks 446d

Analysts Are Bullish on Top Healthcare Stocks: Gossamer Bio (GOSS), Reneo Pharmaceuticals (RPHM)

Benzinga 450d

Over $65M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Seeking Alpha 450d

Reneo Pharmaceuticals GAAP EPS of -$0.60 in-line Follow us on: See also:

Indices

Commodities

Currencies

Stocks

See more - Explore more categoriesYour Privacy Choices California Consumer Privacy Act (CCPA) Opt-Out Icon Insider Logo

ncG1vNJzZmilkae4psDSZ5muq5mjsrS%2FyKeqopyVp3uku8xopZ6vo2S%2FsbTMZqqtp5Og